Company information
- Ticker
- 6762
- Country
- Taiwan
- Sector
- Health Care
- Industry
- Biotech
Delta Asia Business Summary
Delta Asia International Corporation (6762.TWO) operates as a premier high-end medical device Contract Development and Manufacturing Organization (CDMO), specializing in the precision engineering of Class II and Class III medical devices. The company generates revenue through a vertically integrated service model that includes mold development, precision injection molding, and the assembly of semi-finished and finished medical products. Its primary business segments are categorized by these manufacturing stages, serving a client base that is 100% concentrated in the United States, including industry giants such as Johnson & Johnson (Ethicon), Abbott, and Hologic. Delta Asia’s product portfolio is highly specialized, focusing on components for minimally invasive surgical robots, cardiovascular equipment, and automated insulin delivery systems. Within the competitive landscape, the company competes directly with other specialized medical manufacturers such as Intai Technology, Medeologix, and Janman Precision, distinguishing itself through its ability to maintain extreme tolerances and cleanroom standards required for invasive surgical applications. The company was founded in 2004 by Yawen Xu (Hsu, Ya-Wen), who currently serves as both Chairman and CEO. Xu, who established the firm at age 24, successfully pivoted the business from consumer electronics to high-stakes medical manufacturing in 2008 to escape the low-margin commoditization of the electronics sector. The leadership team is further strengthened by Deputy General Manager Hongwen Wei (Wei, Hung-Wen), who oversees operational strategy and investor relations. A pivotal figure in the company’s trajectory is Dr. Chang You-De (Yue-Teh Jang), a renowned medical device innovator and Chairman of MedeonBio (6499.TWO), which serves as a major strategic shareholder and board member. This leadership pedigree, combined with the technical expertise of long-term executives like Accounting Supervisor Fang Cheng Lu, has positioned Delta Asia as a critical node in the global supply chain for advanced surgical instrumentation and chronic disease management hardware.